National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concern.

Simone Périnet, Anson Williams, Laurence Campeau, Janelle Elliott, Fan Zhang, Qiuying Yang, Joseph Cox, Karelyn Davis, Jordan J Feld, Marina B Klein, Nadine Kronfli, Mia J Biondi, Peter K Daley, Nashira Popovic
{"title":"National hepatitis B and C estimates for 2021: Measuring Canada's progress towards eliminating viral hepatitis as a public health concern.","authors":"Simone Périnet, Anson Williams, Laurence Campeau, Janelle Elliott, Fan Zhang, Qiuying Yang, Joseph Cox, Karelyn Davis, Jordan J Feld, Marina B Klein, Nadine Kronfli, Mia J Biondi, Peter K Daley, Nashira Popovic","doi":"10.14745/ccdr.v51i67a02","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of morbidity and mortality worldwide. Measuring the epidemiological burden of HCV and HBV in Canada is essential to measure progress towards global elimination targets and to ultimately eliminate viral hepatitis as a public health concern.</p><p><strong>Objective: </strong>This study aimed to provide the first national estimates of HBV prevalence and unawareness, and to update estimates of HCV incidence, prevalence, and unawareness in the general population and key populations in Canada for 2021. Progress towards elimination targets for 2025, namely incidence, awareness, mortality, and HBV vaccination, was also assessed.</p><p><strong>Methods: </strong>A combination workbook method and mathematical modelling was used to estimate the prevalence and unawareness of chronic hepatitis B (CHB), prevalence and incidence of anti-HCV antibodies, and the prevalence and unawareness of chronic hepatitis C (CHC).</p><p><strong>Results: </strong>The estimated prevalence of CHB was 0.68% (plausible range: 0.40%-0.97%) or 262,000 (152,000-371,000) people in the general population, of whom 42.5% (33.9%-51.0%) were unaware of their infection. Immigrants from countries where HBV is common had the highest prevalence at 4.2% (1.9%-5.6%). An estimated 8,212 new HCV infections occurred in 2021, and the estimated prevalence of CHC was 0.56% (0.15%-0.97%) or 214,000 (58,500-369,000) people, of whom 41.5% (34.3%-48.8%) were unaware of their infection. People who inject drugs had the highest prevalence and largest proportion who were unaware at 36.9% (12.6%-55.1%) and 49.9% (29.0%-70.2%), respectively.</p><p><strong>Conclusion: </strong>While the overall viral hepatitis burden is low in the general Canadian population, these estimates indicate that certain populations and communities remain disproportionately affected. Although Canada has met some of the 2025 targets, more work is needed. To this end, efforts to obtain and standardize provincial and national data will be required to measure progress towards all elimination targets.</p>","PeriodicalId":94304,"journal":{"name":"Canada communicable disease report = Releve des maladies transmissibles au Canada","volume":"51 6-7","pages":"223-237"},"PeriodicalIF":0.0000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12372649/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canada communicable disease report = Releve des maladies transmissibles au Canada","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14745/ccdr.v51i67a02","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of morbidity and mortality worldwide. Measuring the epidemiological burden of HCV and HBV in Canada is essential to measure progress towards global elimination targets and to ultimately eliminate viral hepatitis as a public health concern.

Objective: This study aimed to provide the first national estimates of HBV prevalence and unawareness, and to update estimates of HCV incidence, prevalence, and unawareness in the general population and key populations in Canada for 2021. Progress towards elimination targets for 2025, namely incidence, awareness, mortality, and HBV vaccination, was also assessed.

Methods: A combination workbook method and mathematical modelling was used to estimate the prevalence and unawareness of chronic hepatitis B (CHB), prevalence and incidence of anti-HCV antibodies, and the prevalence and unawareness of chronic hepatitis C (CHC).

Results: The estimated prevalence of CHB was 0.68% (plausible range: 0.40%-0.97%) or 262,000 (152,000-371,000) people in the general population, of whom 42.5% (33.9%-51.0%) were unaware of their infection. Immigrants from countries where HBV is common had the highest prevalence at 4.2% (1.9%-5.6%). An estimated 8,212 new HCV infections occurred in 2021, and the estimated prevalence of CHC was 0.56% (0.15%-0.97%) or 214,000 (58,500-369,000) people, of whom 41.5% (34.3%-48.8%) were unaware of their infection. People who inject drugs had the highest prevalence and largest proportion who were unaware at 36.9% (12.6%-55.1%) and 49.9% (29.0%-70.2%), respectively.

Conclusion: While the overall viral hepatitis burden is low in the general Canadian population, these estimates indicate that certain populations and communities remain disproportionately affected. Although Canada has met some of the 2025 targets, more work is needed. To this end, efforts to obtain and standardize provincial and national data will be required to measure progress towards all elimination targets.

Abstract Image

Abstract Image

Abstract Image

2021年全国乙型和丙型肝炎估计:衡量加拿大在消除病毒性肝炎这一公共卫生问题方面的进展。
背景:乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染是世界范围内发病率和死亡率的主要原因。测量加拿大HCV和HBV的流行病学负担对于衡量实现全球消除目标的进展以及最终消除作为公共卫生问题的病毒性肝炎至关重要。目的:本研究旨在提供首个全国HBV患病率和不知情情况的估计,并更新2021年加拿大普通人群和重点人群中HCV发病率、患病率和不知情情况的估计。还评估了实现2025年消除乙肝病毒目标(即发病率、认识、死亡率和乙肝疫苗接种)的进展情况。方法:采用工作手册法和数学模型相结合的方法,对慢性乙型肝炎(CHB)的患病率和不知情情况、抗hcv抗体的患病率和发病率以及慢性丙型肝炎(CHC)的患病率和不知情情况进行估计。结果:CHB的估计患病率为0.68%(合理范围:0.40% ~ 0.97%)或26.2万人(15.2万~ 37.1万人),其中42.5%(33.9% ~ 51.0%)不知道自己感染了CHB。来自HBV常见国家的移民的患病率最高,为4.2%(1.9%-5.6%)。2021年估计发生了8212例新的HCV感染,CHC的估计患病率为0.56%(0.15%-0.97%)或214,000人(58,500-369,000),其中41.5%(34.3%-48.8%)不知道自己的感染。注射吸毒者患病率最高,不知情者所占比例最大,分别为36.9%(12.6% ~ 55.1%)和49.9%(29.0% ~ 70.2%)。结论:虽然加拿大一般人群的病毒性肝炎总体负担较低,但这些估计表明某些人群和社区仍然不成比例地受到影响。尽管加拿大已经实现了2025年的部分目标,但仍需要做更多的工作。为此目的,将需要努力取得省级和国家数据并使之标准化,以衡量实现所有消除目标的进展情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信